Articles On Imugene (ASX:IMU)

Highlights The benchmark ASX 200 index was trading 0.44% up at 7,512 in the first 10 minutes of trading. Wall Street rallied to close higher on Wednesday. The materials and utilities sectors were enjoying the most gains, rising 0.54%...

Clinical stage immuno-oncology company Imugene (ASX:IMU) says City of Hope in the US has dosed the first cohort two patient in the Phase I clinical trial of the company's oncolytic virotherapy candidate.

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

ASX rallies after opening lower today Energy stocks lead the pack on higher oil prices Australia CPI is due tomorrow   Local blue chips brushed off early jitters to finish the day higher by 0.32%. The ASX was bracing for another day of lo...

Highlights The benchmark ASX 200 index was trading 0.25% up at 7,473 in the first 15 minutes of trading. US inflation rose to 8.5% in March 2022, highest since 1981. PointsBet’s wholly owned subsidiary PointsBet Pennsylvania LLC has s...

Highlights ASX 200 fell 0.4%, or 31.2 points, to 7454, weighed down by losses across healthcare and technology sectors. Market sentiments are being powered by developments around Russia-Ukraine war and heightened inflationary concerns...

ASX 200 slipped 0.42% Russia bonds deemed to have defaulted by S&P Afterpay net loss is growing  Local shares slipped by 0.42% today on growing concerns that imminent rate hikes could trigger a revaluation of equities. It was a sea of...

The Australian share market fell to its lowest in two weeks after a global retreat from risk lowered commodity prices and US equities. The S&P/ASX 200 finished 31 points or 0.42 per cent in the red at 7454 after trading as low as 743...

A broad sell-off lowered Australian shares in the wake of sharp declines on Wall Street and commodity markets overnight. The S&P/ASX 200 declined steadily to a mid-session loss of 40 points or 0.53 per cent. All 11 sectors retreat...

ASX 200 healthcare shares have struggled for the past six months, let’s face it. After peaking at 52-week highs of 47,760 back in September 2021, the S&P/ASX 200 Health Care Index (ASX: XHJ) now rests at 39,861. That’s a 16.5% decline...

ASX was down 0.5% The US Fed signals tightening Aussie payrolls jobs almost flat in March   The ASX followed Wall Street into the red, falling by 0.60% as market sentiment turned sour following some Fed news overnight. Minutes from the la...

The share market fell for a second day as global financial markets continued to adjust to a fast-changing rates outlook. The S&P/ASX 200 dropped 47 points or 0.63 per cent to its lowest close in a week and a half. Rate-sensitive g...

ASX 200 is within striking range of record level Tech sector jumps 3% RBA keeps cash rate at 0.1% Local blue chip shares closed flat despite a big rally in Tech stocks. The ASX 200, currently at 7,516, is now within range of its record le...

ASX 200 extends winning streak US bonds have sharply inverted, sparking concerns of a potential recession China says it has found a new Omicron sub-variant   It was a sea of green today on the ASX, as local investors shrugged off a rapid...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Highlights ASX 200 inched 0.2% lower after news that Australia would impose a 35% tariff on Russian imports. Despite the fall, ASX 200 ended March 2022 with a healthy gain of over 6%. Investors globally are tracking updates about the...

The healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two million people. Treasurer Josh Frydenberg announced last night that Australia’s health budget will top $132bn in 2022-23, up from $62bn a decade...

eInvest MD Camilla Love discusses five ways to spot whether your ESG investment manager is authentic Apostle’s Fiona Manning talks about the new People and Planet Fund, which takes a zero-tolerance approach to ESG investing The Ethical In...

The Imugene Limited (ASX: IMU) share price is on the move today. This comes after the company announced an update on its phase 1 clinical trial of its oncolytic virotherapy candidate, Checkvacc. Checkvacc is a novel treatment currently be...

The Uniti Group Ltd (ASX: UWL) share price surged to an all-time high before the company’s shares went into a trading halt late Wednesday afternoon. Shares in the fibre broadband company rallied 10.7% to $4.67. This made it the top S&P...

The share market logged its highest close in nine weeks as banks and battered growth stocks took over the running from miners and oil producers. The S&P/ASX 200 climbed 37 points or 0.5 per cent to its fourth gain in five sessions. A...

23 Mar 2022 - Imugene (ASX:IMU) has received approval from the western institutional review board to commence a phase 1 clinical trial of its oncolytic virotherapy candidate, VAXIN…

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is pushing higher for a second day in a row. At the time of writing, the benchmark index is up 0.3% to 7,362.1 points. Four ASX shares that are climbing more than most today are list...

Banking and tech stocks steered the share market towards its fifth gain in six sessions after a pause in rising energy prices helped Wall Street advance overnight. The S&P/ASX 200 climbed 30 points or 0.4 per cent to a nine-week high...

Imugene (IMU) receives the go-ahead to start a phase-one clinical trial of its oncolytic virotherapy candidate VAXINIA in treating patients with multiple solid tumours in the US Oncolytic viruses are designed to selectively kill tumour cel...

The Imugene Ltd (ASX: IMU) share price is climbing today on the back of a clinical update from the biotech company. Imugene shares are currently trading at 28 cents, a 7.69% gain. In contrast, the  S&P/ASX 200 Index (ASX: XJO) is up...

Mining, Energy were the two best sectors today Tech was the worst performer following J Powell comments   Blue chip shares resumed their winning ways, posting a 1% gain today with miners and energy stocks leading the way. The ASX 200 inde...

ASX lost momentum in afternoon session after making early gains Aussie dollar is trading over US 74c Magellan’s Hamish Douglass quits   The ASX 200 lost early momentum after erasing a 0.60% gain this morning to finish slightly down by 0.2...

ShareCafeWebinar Recap – SNX, VMS, AU1 & IMU Catch up on the full webinar with presentations from Sierra Nevada Gold (ASX: SNX), Venture Minerals (ASX: VMS), The Agency Group (ASX: AU1)  & Imugene (ASX: IMU) Webinar Recap – SNX, VM...

ShareCafeImugene (ASX: IMU) – Webinar Presentation Leslie Chong – CEO & Managing Director – Imugene develops transformative cancer medicines to improve patients’ lives and to establish value and trust with it’s stakeholders. Imugene (A...

The share market flew to a one-month high after unemployment fell to its lowest since 2008 and the Federal Reserve said the US economy was strong enough to handle an aggressive series of rate rises. The S&P/ASX 200 rallied 101 points...

ASX biotech shares have, as a whole, had a remarkably poor run over the last 6 months. Here’s what we mean. Over the past 6 months, the All Ordinaries Index (ASX: XAO) is down 2.2%. Not what you’d like to see. But not close to gut wrenchin...

It was almost a complete reversal of what happened last week, as commodities tumbled and tech stocks rallied today. The broader ASX 200 index gained 1%, as sentiment shifted towards riskier assets with all 11 sectors in the green. The Tech...

Mining stocks steered the ASX lower as Chinese Covid lockdowns and tentative optimism about Russia-Ukraine peace talks sapped recent gains in commodity prices.   The S&P/ASX 200 declined 52 points or 0.72 per cent. Bulk metals maj...

Aussie shares retreated as declines in commodity prices weighed on miners and energy producers. The S&P/ASX 200 eased 56 points or 0.79 per cent by mid-session. Gains in banks, industrials and property stocks were outweighed by sh...

Clinuvel releases positive preliminary results from pilot study Cann’s Mildura cannabis facility is ready Imugene signs deal with Merck Respiri provides wheezo to children’s hospital in Michigan The ASX 200 Health Index (XHJ) is trading l...

15 Mar 2022 - A snapshot of the stocks on the move featuring Pushpay (ASX:PPH), Imugene (ASX:IMU) & Rio Tinto (ASX:RIO).

The Imugene Limited (ASX: IMU) share price is marching higher in early trade. Imugene shares are up 4% even as the All Ordinaries Index (ASX: XAO) tumbles 1%. The Imugene share price closed yesterday at 25 cents and is currently trading at...

Imugene (IMU) joins forces with Merck & Co for a new clinical trial collaboration and supply agreement for treating gastric cancer Imugene and Merck trade name, MSD, will evaluate the safety and efficacy of Imugene’s HER-Vaxx, a B-cell...

Highlights The ASX Small Ordinaries index surged 1.12% to 3,215.3 by 12:30 PM AEDT. 99L, OEC and MOH are three ASX penny stocks surging higher today. Investors must keep their risk in check and do proper due diligence before investing...

Highlights The benchmark ASX 200 was trading 0.88% up at 7,125 in the first 15 minutes of trading on Monday. Major US stock indices ended lower on Friday as technology and growth shares fell sharply. All 11 sectors are trading higher...

On 8th March 2022, the equity market of Australia ended in red. On the same day, ASX Midcap50 fell by 1.55% and ASX 200 was down by 0.83%. ASX All Ordinaries went down by 0.93% to 7,252.90. Data Source: ASX, Table Source: Copyright © 202...

Highlights The ASX 200 closed lower by 0.8% this afternoon and has dropped below 7,000. Miners continued to drag, but blue chip financials, supermarkets, and healthcare companies are higher. Global markets have been rocked by a sharp...

Today, the S&P/ASX 200 Index (ASX: XJO) broke below 7,000 points once again as miners and energy shares lost their gusto. At the end of the session, the benchmark index finished 0.83% lower at 6,980.3 points. Despite concerns of a mat...

Local blue chip shares fell today, as risk-off sentiment prevails across Asia following the latest development in the energy markets. As Brent pushed above US$125 a barrel in Asian hours, ASX Energy and Mining sectors, which have been the t...

Energy sector rises 5% as oil prices go nuts The benchmark Brent crude continued its rise in Asian trade, surging by another 20% this morning to over US$140 a barrel. It’s since retreated, and at 4pm AEDT, was trading just shy of US$130 a b...

The dollar rose and stocks fell as extreme moves in commodity prices drove Asian markets and US and European futures sharply lower. The S&P/ASX 200 fell 72 points or 1.02 per cent to its lowest close in more than a week. Strong ga...

Patents, partnerships, dose safety and ongoing candidate trials are some of the hallmarks of the company's recent activity that have contributed to the recommendation.

The share market fell steadily all morning as the threat of embargoes on Russian energy exports drove crude prices sharply higher and US and European futures firmly lower.   The S&P/ASX 200 sank 91 points or 1.28 per cent after a bri...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...